Matthew Hayenga

Matthew Hayenga is a seasoned intellectual property attorney with extensive experience in patent litigation and portfolio management, primarily serving in-house defense-side roles for large corporations. His practice encompasses diverse technology areas, including financial technology, artificial intelligence, machine learning, biometric authentication, and code review engines, stemming from his current position. Earlier in his career, he focused on the life sciences, particularly surgical devices (cataract, vitreoretinal, and surgical glaucoma franchises), and was involved in Hatch-Waxman/generic drug litigation.

Hayenga consistently operates on the defendant side, managing and defending against patent infringement claims. His current role is Assistant General Counsel and SVP for Intellectual Property at Bank of America, which he joined in 2022. Prior to Bank of America, he served as the Head of Intellectual Property for the Surgical Franchise at Alcon, and before that, as Head of IP Litigation & Patent Strategy for Alcon, where he oversaw patent prosecution, litigation, and licensing. He also gained experience in private practice as an attorney with Baker Botts in Dallas, TX.

A notable aspect of his litigation experience includes managing Hatch-Waxman/generic drug litigation during his tenure at Alcon, addressing complex pharmaceutical patent disputes. In his current capacity, he has appeared as in-house counsel for Bank of America in cases such as Wapp Tech Limited Partnership et al. v. Bank of America Corporation. While his roles involved managing patent portfolios and litigation strategies that likely included considerations of PTAB proceedings, specific records of his appearances in IPR/PGR proceedings are not readily available.

Matthew Hayenga's professional background includes a clerkship for Judge Sharon Prost at the U.S. Court of Appeals for the Federal Circuit in Washington, DC.